Metagenomi Therapeutics, Inc. (MGX) Shareholders’ equity 2023–2025
Metagenomi Therapeutics, Inc. (MGX) shareholders’ equity at each fiscal year-end, per SEC filings.
$158.6MFY2025 · since FY2023: -$135.6M → $158.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $158.6M | -32.5% |
| FY2024 | $234.9M | +273.2% |
| FY2023 | -$135.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice